Pulse Wave Velocity in Chronic Obstructive Pulmonary Disease and the Impact of Inhaled Therapy (SUMMIT): A Randomized Double-Blind Clinical Trial
Year: 2020
Type: article
Institutions: GlaxoSmithKline (United States), GlaxoSmithKline (United Kingdom), University of Liverpool, Aintree University Hospital, Brigham and Women's Hospital, Harvard University, Weill Cornell Medicine, University of Edinburgh, Manchester Academic Health Science Centre, University of Manchester, Manchester University NHS Foundation Trust, University of Michigan
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Funder: GlaxoSmithKline
Award: G112630316
OpenAlex ID: W3005408523
